Research Article

ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss

Volume: 2 Number: 2 June 29, 2021
EN

ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss

Abstract

Aim : The efficiency of hyperbaric oxygen (HBO) treatment according to ABO blood group system was evaluated in patients with Idiopathic sudden sensorineural hearing loss (ISSNHL). Methods: Serum lipid values and novel atherogenic risk calculations of 346 patients who came to the clinic for HBO treatment were performed. HBO treatment efficiency was evaluated on ABO blood groups. The effect of serum lipid levels and atherogenic risk levels on HBO treatment was measured according to the blood groups of ISSNHL patients. Results: The most important finding is that ISSNHL patients with O blood group antigen benefit the least from HBO therapy. Moreover, patients with O blood group antigen had statistically lower serum lipid values and atrogenic risk index than patients with non-O blood group. In addition, the frequency of O blood group in ISSNHL patients was higher than in non-O blood groups. Conclusions: The effect of serum lipid values and atherogenic risk indices in ISSNHL patients receiving HBO therapy may vary according to ABO blood groups. The relationship between hyperbaric oxygen therapy and the ABO blood grouping system should be supported by further research.

Keywords

Supporting Institution

yok

References

  1. References: 1- Eren E, Yılmaz N, Koctekin B,Birinci S. High-density lipoprotein functionality and AB blood phenotype. Iraqi J Hematol 2020;9:66-71. oi: 10.4103/ijh.ijh_10_20
  2. 2-Yang Y, Hood LJ, McPherson B. Association between ABO blood group status and cochlear/neural function: auditory brainstem response findings. Acta Otolaryngol. 2021 Jan 11:1-6. doi: 10.1080/00016489.2020.1858236.
  3. 3- Birinci, S., Koctekin, B., Eren, E., Yilmaz, N. 2020. Lecithin- cholesterol acyltransferase and relationship with Platelet-activating factor in AB blood phenotype. Bali Medical Journal 9(1): 332-338. DOI: 10.15562/bmj.v9i1.1746
  4. 4- Rhee TM, Hwang D, Lee JS, Park J, Lee JM. Addition of Hyperbaric Oxygen Therapy vs Medical Therapy Alone for Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018 Dec 1;144(12):1153-1161. doi: 10.1001/jamaoto.2018.2133.
  5. 5- Eren, E., Yıldırım, F., Giray, O., Yilmaz, N. (2019). Hyperbaric Oxygen Treatment is Associated with Lipid Inflammatory Response Assessed Using Serum Platelet Activating Factor, Polish Hyperbaric Research, 67(2), 103-108. doi: https://doi.org/10.2478/phr-2019-0009
  6. 6-Henderson D, Subramaniam M, Boettcher FA. Individual susceptibility to noise-induced hearing loss: an old topic revisited. Ear Hear. 1993 Jun;14(3):152-68. doi: 10.1097/00003446-199306000-00002. PMID: 8344472.
  7. 7-Quaranta N, Squeo V, Sangineto M, Graziano G, Sabbà C. High Total Cholesterol in Peripheral Blood Correlates with Poorer Hearing Recovery in Idiopathic Sudden Sensorineural Hearing Loss. PLoS One. 2015 Jul 24;10(7):e0133300. doi: 10.1371/journal.pone.0133300.
  8. 8- Byl FM Jr. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope. 1984 May;94(5 Pt 1):647-61.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

Esin Eren
Türkiye

Furkan Yıldırım This is me
0000-0003-3784-1236
Türkiye

Early Pub Date

April 16, 2024

Publication Date

June 29, 2021

Submission Date

March 15, 2021

Acceptance Date

June 28, 2021

Published in Issue

Year 2021 Volume: 2 Number: 2

APA
Eren, E., Yıldırım, F., Giray, O., & Yılmaz, N. (2021). ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss. Experimental and Applied Medical Science, 2(2), 176-183. https://izlik.org/JA43TR93WZ
AMA
1.Eren E, Yıldırım F, Giray O, Yılmaz N. ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss. Exp Appl Med Sci. 2021;2(2):176-183. https://izlik.org/JA43TR93WZ
Chicago
Eren, Esin, Furkan Yıldırım, Ozlem Giray, and Necat Yılmaz. 2021. “ABO Blood Groups and Hyperbaric Oxygen Therapy Effectiveness in Sudden Hearing Loss”. Experimental and Applied Medical Science 2 (2): 176-83. https://izlik.org/JA43TR93WZ.
EndNote
Eren E, Yıldırım F, Giray O, Yılmaz N (June 1, 2021) ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss. Experimental and Applied Medical Science 2 2 176–183.
IEEE
[1]E. Eren, F. Yıldırım, O. Giray, and N. Yılmaz, “ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss”, Exp Appl Med Sci, vol. 2, no. 2, pp. 176–183, June 2021, [Online]. Available: https://izlik.org/JA43TR93WZ
ISNAD
Eren, Esin - Yıldırım, Furkan - Giray, Ozlem - Yılmaz, Necat. “ABO Blood Groups and Hyperbaric Oxygen Therapy Effectiveness in Sudden Hearing Loss”. Experimental and Applied Medical Science 2/2 (June 1, 2021): 176-183. https://izlik.org/JA43TR93WZ.
JAMA
1.Eren E, Yıldırım F, Giray O, Yılmaz N. ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss. Exp Appl Med Sci. 2021;2:176–183.
MLA
Eren, Esin, et al. “ABO Blood Groups and Hyperbaric Oxygen Therapy Effectiveness in Sudden Hearing Loss”. Experimental and Applied Medical Science, vol. 2, no. 2, June 2021, pp. 176-83, https://izlik.org/JA43TR93WZ.
Vancouver
1.Esin Eren, Furkan Yıldırım, Ozlem Giray, Necat Yılmaz. ABO blood groups and hyperbaric oxygen therapy effectiveness in sudden hearing loss. Exp Appl Med Sci [Internet]. 2021 Jun. 1;2(2):176-83. Available from: https://izlik.org/JA43TR93WZ

    22718              20542      20690    20805   21108       22245 

22392     22717